Ocular Therapeutix, INC Form 4 insider transactions

Pravin Dugel, Executive Chairman, President, and CEO of Ocular Therapeutix, sold shares to cover tax obligations related to vesting restricted stock units.

Summer Road LLC, a family office, purchased 930,851 shares of Ocular Therapeutix (OCUL) at $7.52 per share through a private placement.